🇺🇸 Antibody-Drug Conjugates in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 4
Most-reported reactions
- Nasal Discomfort — 1 report (25%)
- Off Label Use — 1 report (25%)
- Sneezing — 1 report (25%)
- Throat Irritation — 1 report (25%)
Other Oncology approved in United States
Frequently asked questions
Is Antibody-Drug Conjugates approved in United States?
Antibody-Drug Conjugates does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Antibody-Drug Conjugates in United States?
Hellenic Cooperative Oncology Group is the originator. The local marketing authorisation holder may differ — check the official source linked above.